Trials / Completed
CompletedNCT03481426
The Effect of Workplace Interventions on the Treatment of Low-back Pain
Workplace Interventions Supporting Employees to Continue at Work: Participatory Actions Organized by OH Physiotherapist
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 107 (actual)
- Sponsor
- Finnish Institute of Occupational Health · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The study evaluates the effect of workplace interventions on work ability promotion among workers with back problems. The half of participant will receive Information, advice and guidance for back problems in addition to participatory workplace actions organized by Occupational Health Physiotherapist. The other half will receive only Information, advice and guidance without workplace intervention.
Detailed description
Musculoskeletal symptoms, especially back pain, account for the majority of days lost. In order to enhance the health and working careers of people with MSD, it is important that work can be arranged in such a way that they can remain in work life despite MSD.In the field of work ability promotion, various stakeholders; the worker, employer, professionals in occupational health services (OHS) interact to optimize actions and practices to prevent absences from work and promote remaining at work. This study aims to investigate participatory working practices and modles of co-operation among OHS and workplaces.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Workplace intervention | The study contains normal services of occupational health. Both intervention groups are based on voluntary will, and the normal care and services are guaranteed. In the intervention group new working method which improve co-operation between occupational health services and workplaces. |
Timeline
- Start date
- 2017-02-01
- Primary completion
- 2019-04-30
- Completion
- 2019-08-30
- First posted
- 2018-03-29
- Last updated
- 2021-04-08
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT03481426. Inclusion in this directory is not an endorsement.